Invasive pulmonary aspergillosis secondary to microwave ablation: a multicenter retrospective study

References

• Schneider T, Heussel CP, Herth FJ, et al. Thermal ablation of malignant lung tumors. Dtsch Arztebl Int. 2013;110:394–400.
   PubMed Web of Science ®Google Scholar
• Song Z, Qi H, Zhang H, et al. Microwave ablation: results with three different diameters of antennas in ex vivo bovine and in vivo porcine liver. J Cancer Res Ther. 2017;13(5):737–741.
   PubMed Web of Science ®Google Scholar
• Lubner MG, Brace CL, Hinshaw JL, et al. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol. 2010;21:S192–S203.
   PubMed Web of Science ®Google Scholar
• Wasser EJ, Dupuy DE. Microwave ablation in the treatment of primary lung tumors. Semin Respir Crit Care Med. 2008;29:384–394.
   PubMed Web of Science ®Google Scholar
• Wolf FJ, Grand DJ, Machan JT, et al. Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients. Radiology. 2008;247:871–879.
   PubMed Web of Science ®Google Scholar
• Carrafiello G, Mangini M, Fontana F, et al. Microwave ablation of lung tumours: single-centre preliminary experience. Radiol Med. 2014;119:75–82.
   PubMed Web of Science ®Google Scholar
• Belfiore G, Ronza F, Belfiore MP, et al. Patients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patients. Eur J Radiol. 2013;82:177–181.
   PubMed Web of Science ®Google Scholar
• Wei Z, Ye X, Yang X, et al. Microwave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancer. Cardiovasc Intervent Radiol. 2015;38:135–142.
   PubMed Web of Science ®Google Scholar
• Acksteiner C, Steinke K. Percutaneous microwave ablation for early-stage non-small cell lung cancer (NSCLC) in the elderly: a promising outlook. J Med Imaging Radiat Oncol. 2015;59:82–90.
   PubMed Web of Science ®Google Scholar
• Yang X, Ye X, Huang G, et al. Repeated percutaneous microwave ablation for local recurrence of inoperable Stage I nonsmall cell lung cancer. J Cancer Res Ther. 2017;13(4):683–688.
   PubMed Web of Science ®Google Scholar
• Li B, Wang Z, Zhou K, et al. Safety and feasibility within 24 h of discharge in patents with inoperable malignant lung nodules after percutaneous microwave ablation. J Cancer Res Ther. 2016 Dec;12(Suppl):C171–C175.
   PubMedGoogle Scholar
• Ni Y, Bi J, Ye X, et al. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: a pilot study. Medicine (Baltimore). 2016;95:e3998.
   PubMed Web of Science ®Google Scholar
• Zheng A, Wang X, Yang X, et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg. 2014;98:243–248.
   PubMed Web of Science ®Google Scholar
• Huang G, Liu Q, Ye X, et al. Invasive pulmonary aspergillosis: a rare complication after microwave ablation. Int J Hyperthermia. 2014;30:412–417.
   PubMed Web of Science ®Google Scholar
• Ong CK, Lirk P, Seymour RA, et al. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth Analg. 2005;100:757–773.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–1821.
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327–360.
   PubMed Web of Science ®Google Scholar
• Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008;47:674–683.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;235:728–739.
   PubMed Web of Science ®Google Scholar
• Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis. 2001;33:1824–1833.
   PubMed Web of Science ®Google Scholar
• Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12:310–350.
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Sugui JA. Aspergillus fumigatus–what makes the species a ubiquitous human fungal pathogen? PLoS Pathog. 2013;9:e1003743.
   PubMed Web of Science ®Google Scholar
• Patterson KC, Strek ME. Diagnosis and treatment of pulmonary aspergillosis syndromes. Chest. 2014;146:1358–1368.
   PubMed Web of Science ®Google Scholar
• Liss B, Vehreschild JJ, Bangard C, et al. Our 2015 approach to invasive pulmonary aspergillosis. Mycoses. 2015;58:375–382.
   PubMed Web of Science ®Google Scholar
• Chabi ML, Goracci A, Roche N, et al. Pulmonary aspergillosis. Diagn Interv Imaging. 2015;96:435–442.
   PubMed Web of Science ®Google Scholar
• Schwartz S, Thiel E. Clinical presentation of invasive aspergillosis. Mycoses. 1997;40 (Suppl 2):21–24.
   PubMedGoogle Scholar
• Greene RE, Schlamm HT, Oestmann JW, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373–379.
   PubMed Web of Science ®Google Scholar
• Samarakoon P, Soubani A. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis. 2008;5:19–27.
   PubMedGoogle Scholar
• Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect. 2001;7:25–31.
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42:1417–1427.
   PubMed Web of Science ®Google Scholar
• Hage CA, Knox KS, Davis TE, et al. Antigen detection in bronchoalveolar lavage fluid for diagnosis of fungal pneumonia. Curr Opin Pulm Med. 2011;17:167–171.
   PubMed Web of Science ®Google Scholar
• Metan G, Koç AN, Atalay A, et al. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies? Scand J Infect Dis. 2012;44:330–336.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Pecori D, Della Siega P, et al. Current and future therapies for invasive aspergillosis. Pulm Pharmacol Ther. 2015;32:155–165.
   PubMed Web of Science ®Google Scholar
• Blot F, Edé C, Nitenberg GM. Voriconazole versus amphotericin B for invasive aspergillosis. N Engl J Med. 2002;347:2080–2081.
   PubMedGoogle Scholar
• Karthaus M. Voriconazole versus amphotericin B for invasive aspergillosis. N Engl J Med. 2002;347:2080–2081.
   PubMed Web of Science ®Google Scholar
• Kravitz JN, Berry MW, Schabel SI, et al. A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest. 2013;143:1414–1421.
   PubMed Web of Science ®Google Scholar